Statistics
Publications
6
Citations
4.2K
H-Index
6
Active since
2021
Nanami Morizako is an author at National Institute of Infectious Diseases.
Publications per year
2021–2022
6
6
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar et al. · Nature · 2021 · 1.4K citations · Full text
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira et al. · Nature · 2022 · 1.1K citations · Full text
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 735 citations · Full text
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Akatsuki Saito, Takashi Irie, Rigel Suzuki et al. · Nature · 2021 · 664 citations · Full text
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu et al. · Cell Reports · 2021 · 196 citations · Full text
1–5 of 6